HK1027514A1 - Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution - Google Patents

Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution

Info

Publication number
HK1027514A1
HK1027514A1 HK00106889A HK00106889A HK1027514A1 HK 1027514 A1 HK1027514 A1 HK 1027514A1 HK 00106889 A HK00106889 A HK 00106889A HK 00106889 A HK00106889 A HK 00106889A HK 1027514 A1 HK1027514 A1 HK 1027514A1
Authority
HK
Hong Kong
Prior art keywords
thrombomodulin
aqueous
solution
distribution
storage
Prior art date
Application number
HK00106889A
Other languages
English (en)
Inventor
Masaki Yui
Akira Yokozawa
Tomoyo Murata
Kazuhisa Tsuruta
Hirotomo Shimizu
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26554271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1027514(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of HK1027514A1 publication Critical patent/HK1027514A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
HK00106889A 1997-10-15 2000-10-30 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution HK1027514A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28165997 1997-10-15
JP30852397 1997-11-11
PCT/JP1998/004609 WO1999018994A1 (fr) 1997-10-15 1998-10-13 Procede pour conserver la qualite d'une solution parenterale aqueuse de thrombomoduline pour l'entreposage ou la distribution

Publications (1)

Publication Number Publication Date
HK1027514A1 true HK1027514A1 (en) 2001-01-19

Family

ID=26554271

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106889A HK1027514A1 (en) 1997-10-15 2000-10-30 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution

Country Status (14)

Country Link
US (1) US6808706B1 (ko)
EP (1) EP1029548B1 (ko)
JP (1) JP4460762B2 (ko)
KR (1) KR100373480B1 (ko)
CN (1) CN1275916A (ko)
AT (1) ATE358496T1 (ko)
AU (1) AU729876B2 (ko)
CA (1) CA2306206A1 (ko)
DE (1) DE69837493T2 (ko)
DK (1) DK1029548T3 (ko)
ES (1) ES2281137T3 (ko)
HK (1) HK1027514A1 (ko)
PT (1) PT1029548E (ko)
WO (1) WO1999018994A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006346494A (ja) * 1999-02-22 2006-12-28 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
US6585971B1 (en) * 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
MXPA02006266A (es) * 1999-12-22 2002-12-05 Glaxo Group Ltd Metodos para preparar formulaciones farmaceuticas..
WO2001068820A1 (en) * 2000-03-14 2001-09-20 Anton Mayr Altered strain of the modified vaccinia virus ankara (mva)
WO2003061687A1 (en) * 2002-01-18 2003-07-31 Asahi Kasei Pharma Corporation High-concentration preparation of soluble thrombomodulin
EP2021030A2 (en) * 2006-04-21 2009-02-11 Amgen, Inc. Buffering agents for biopharmaceutical formulations
NZ579873A (en) * 2007-03-23 2011-11-25 Asahi Kasei Pharma Corp Method for producing soluble thrombomodulin of high purity
CN102202643A (zh) * 2008-02-07 2011-09-28 安姆根有限公司 稳定化的蛋白组合物
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
SG188487A1 (en) * 2010-09-17 2013-05-31 Baxter Int Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
EP3043774B1 (en) 2013-09-11 2020-11-04 Eagle Biologics, Inc. Liquid protein formulations containing ionic liquids
EP3200804A4 (en) 2014-10-01 2018-04-18 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0816495A1 (en) 1987-01-08 1998-01-07 Asahi Kasei Kogyo Kabushiki Kaisha DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same
JP2738428B2 (ja) * 1987-01-08 1998-04-08 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチド
US4912207A (en) 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
JPH02255699A (ja) 1989-03-28 1990-10-16 Asahi Chem Ind Co Ltd 新規血液抗凝固物質及びその製法
JPH05213998A (ja) 1990-08-03 1993-08-24 Asahi Chem Ind Co Ltd 新規なポリペプチド及びこれを有効成分とする 医薬組成物
JPH05310787A (ja) 1992-05-01 1993-11-22 Asahi Chem Ind Co Ltd 新規なポリペプチド
JP3007785B2 (ja) 1993-03-16 2000-02-07 旭化成工業株式会社 トロンボモジュリン組成物およびその変性防止方法
ATE151391T1 (de) * 1993-12-13 1997-04-15 Peter Lisec Vorrichtung zum teilen von verbundglas
EP0689843B1 (en) 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins

Also Published As

Publication number Publication date
KR20010031153A (ko) 2001-04-16
EP1029548B1 (en) 2007-04-04
CA2306206A1 (en) 1999-04-22
US6808706B1 (en) 2004-10-26
KR100373480B1 (ko) 2003-02-25
EP1029548A1 (en) 2000-08-23
JP4460762B2 (ja) 2010-05-12
DE69837493T2 (de) 2007-12-13
PT1029548E (pt) 2007-05-31
EP1029548A4 (en) 2004-07-14
WO1999018994A1 (fr) 1999-04-22
ES2281137T3 (es) 2007-09-16
AU729876B2 (en) 2001-02-15
DE69837493D1 (de) 2007-05-16
DK1029548T3 (da) 2007-07-02
ATE358496T1 (de) 2007-04-15
AU9460398A (en) 1999-05-03
CN1275916A (zh) 2000-12-06

Similar Documents

Publication Publication Date Title
HK1027514A1 (en) Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
HK29996A (en) Dispenser adapted for combined continuous and instant operation
CA2135804A1 (en) Syringe with retractable needle
GR3015340T3 (en) Stable aqueous preparation.
DE69412120D1 (de) Implantat-aufbau
BR8702610A (pt) Composicao de microemulsao estavel,composicao limpadora e composicao liquida concentrada na forma de uma microemulsao
DE68903985D1 (de) Behaelter fuer den transport von transplantaten.
EP0361680A3 (en) Morphine-containing composition
IL81658A0 (en) Device for the administration of medicament suspensions
ATE337812T1 (de) Gerät zur verabreichung einer konstanten pulvermenge
HK15494A (en) Non chiral liquid crystalline 2,5-disubstituted 1,3,4-thiadiazoles with extended smectic c-phases
TW367247B (en) Storage container for Vitamin D solution and transfusion container
DE69232957D1 (de) Mit flüssigen Infusionen gefüllte Behälter
EP0577335A3 (en) Storage stable one-part organosiloxane compositions and methods for preparing same
CA2122445A1 (en) A method and device for dosing a liquid preparation
ES2059728T3 (es) Composicion detergente liquida.
IL105533A0 (en) Stable injectable polypeptide compositions
GB8713849D0 (en) Acaricidal formulation
EP0209498A3 (en) A pot for ornamental plants and the like
JPS6443173A (en) Tasteful drink sealed in container
GB2254079B (en) Optically active dioxanes and pyrimidines useful as liquid crystal additives
EP0356367A3 (en) Liquid medium for infusion and preservation of organs
EP0312210A3 (en) Optically active liquid crystalline compounds and compositions containing them
SE8803481D0 (sv) Low viscosity stable non-aqueous suspension containing organophilic clay and low density filler
MX9707121A (es) Formulaciones liquidas de gch.

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: ASAHI KASEI PHARMA CORPORATION

Free format text: FORMER OWNER(S): ASAHI KASEI KABUSHIKI KAISHA

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161013